Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Efficacy and Safety of Zavegepant for the Acute Treatment of Migraine in Women: Results from 2 Randomized, Placebo-controlled Clinical Trials

Author:Mullin, Kathleen   Fountaine, Robert J   Mosher, Linda   

Session Name:P6: Headache: Therapeutics 1  

Topic:Headache  

Program Number:P6.004  

Author Institution:New England Institute for Clinical Research, Stamford, CT  Pfizer Inc, Groton, CT  

Acute Treatment of Migraine with Zavegepant Nasal Spray Reduces the Use of Select Analgesics

Author:Kudrow, David   Mosher, Linda   Straghan, Esther   Sweeney, Samantha   Fountaine, Robert   

Session Name:P9: Headache: Advances in CGRP Inhibition 3  

Topic:Headache  

Program Number:P9.001  

Author Institution:The Los Angeles Headache Center, Los Angeles, CA  Pfizer Inc, Groton, CT  Pfizer Inc, New York, NY  

Physiologically-based Pharmacokinetic Modeling for Assessment of the Drug-drug Interaction Potential of Zavegepant

Author:Ke, Alice   Callegari, Ernesto   Bhardwaj, Rajinder   Varma, Manthena   Muto, Chieko   Bertz, Richard   Sahasrabudhe, Vaishali   Liu, Jing   

Session Name:P9: Headache: Advances in CGRP Inhibition 3  

Topic:Headache  

Program Number:P9.006  

Author Institution:Certara USA, Princeton, NJ  Pfizer Inc, Groton, CT  Pfizer R&D Japan, Tokyo, Japan  Biohaven Pharmaceuticals, New Haven, CT